跳到正文
iScience· Murata·收录于· 1 天前

Efficacy of second-line therapies for SMARCA4-mutated NSCLC based on a nationwide comprehensive genomic profiling database

Efficacy of second-line therapies for SMARCA4-mutated NSCLC based on a nationwide comprehensive genomic profiling database

来源:iScience · doi.org